Want to join the conversation?
$LB 2Q15 Call: Foreign currency negatively impacted our sales growth by about 1BP. Gross margin rate increased by 130BP to 40.3%, driven by an increase in merchandise margin rate. SG&A expenses deleveraged by 70BP, primarily driven by our investment in store selling to improve customer experience.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.